The global dry eye syndrome treatment market Size was valued at USD 5.87 billion in 2021 and expected to reach a value of USD 10.81 billion by 2028, growing at a CAGR of 9.11% during the forecast period 2022-2028. by treatment type (Lubricant Eye Drops, Anti-inflammatory Drugs, Autologous Serum Eye Drops, Nutrition supplements), disease type (Evaporative dry eye syndrome, Aqueous dry eye syndrome), distribution channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Others) and Geography - Global/Region/Country Forecast to 2028.” The global dry eye syndrome market size was valued at USD 5.87 billion in 2021, growing at a CAGR of 9.11% during the forecast period 2022-2028.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/global-dry-eye-syndrome-treatment-market/        

An overview on the Dry Eye Syndrome Treatment Market

Dry eye syndrome causes due to the ocular surface diseases like meibomian gland dysfunction and ocular allergy. It is an ocular illness caused due to the lack of tear fluid for lubricating the eyes, which leads to issues in team film instability, vision and discomfort causes potential damage to the ocular surface. Excessive tearing, grittiness, ocular irritation, mucoid discharge, blurred vision and hyperaemia are a few common symptoms associated with dry eye syndrome. This syndrome is measured by a thin strip of filter paper positioned at the edge of the eye, called a Schirmer test for measuring the amount of tears present in the eye. The patents of different dry eye syndrome treatment drugs are in expiry stage hence different pharmaceutical companies are involved in the R&D of novel drugs actively.

There are a few factors that fuel the dry eye syndrome treatment market such as the overuse of computer screen, steady government support for medical research has enabled researchers for treating such condition completely and growing consciousness regarding treatment and diagnosis of dry eye syndrome amid people. Increase in the prevalence of thyroid disorders, diabetes, rheumatoid arthritis and a deficiency lupus might bolster the dry eye syndrome treatment market. On the other hand, the popularity of self-medication by the patients and expiration of blockbuster drug patents are factors hamper the growth of dry eye syndrome treatment market over the forthcoming years.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=15843

North America accounted for major share in the Dry Eye Syndrome Treatment Market

North America is leading the dry eye syndrome treatment market among other regions because of the increasing usage of medication including antidepressants, antihistamines, pain relievers also increase the threat of dry eye syndrome and high prevalence of lifestyle disorders which increase the changes of contracting dry eye syndrome. Europe got a leading share in dry eye syndrome treatment market due to the growing R&D activities and increasing healthcare infrastructure. Strong government support and growing population mainly in India and China are driving the market in Asia Pacific.

Competitive Analysis - Dry Eye Syndrome Treatment Market

A few major players working in the dry eye syndrome treatment market are Novartis AG (Switzerland), Nicox (France), Allergan (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), Otsuka Holdings Co., Ltd. (Japan), Auven Therapeutics (U.S.) and AFT Pharmaceuticals (New Zealand). Key players in the market focus on following major strategies such as collaborations, mergers and novel product launch.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747